Aolin Li

888 total citations
34 papers, 639 citations indexed

About

Aolin Li is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aolin Li has authored 34 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aolin Li's work include RNA modifications and cancer (8 papers), CRISPR and Genetic Engineering (5 papers) and Cancer-related molecular mechanisms research (5 papers). Aolin Li is often cited by papers focused on RNA modifications and cancer (8 papers), CRISPR and Genetic Engineering (5 papers) and Cancer-related molecular mechanisms research (5 papers). Aolin Li collaborates with scholars based in China, United Kingdom and Canada. Aolin Li's co-authors include Donghui Wen, Yan Zhang, Huimin Xie, Tianjiao Dai, Feifei Li, Lüjun Chen, Yuchen Liu, Congcong Cao, Zhiming Cai and Lin Yao and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Environmental Science & Technology.

In The Last Decade

Aolin Li

33 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aolin Li China 12 294 285 121 83 83 34 639
Weitao Shen China 16 384 1.3× 194 0.7× 69 0.6× 64 0.8× 230 2.8× 34 808
Qian Qian Wang China 17 390 1.3× 87 0.3× 114 0.9× 147 1.8× 45 0.5× 35 812
Xiran Wang China 14 147 0.5× 51 0.2× 62 0.5× 37 0.4× 45 0.5× 46 509
Zihan Dai United States 15 178 0.6× 234 0.8× 15 0.1× 191 2.3× 40 0.5× 30 567
K.N. ArulJothi India 13 156 0.5× 88 0.3× 16 0.1× 82 1.0× 45 0.5× 37 481
Davoud Farajzadeh Iran 15 190 0.6× 92 0.3× 27 0.2× 26 0.3× 31 0.4× 44 539
Haiyan Wei China 21 467 1.6× 100 0.4× 41 0.3× 153 1.8× 297 3.6× 45 1.0k

Countries citing papers authored by Aolin Li

Since Specialization
Citations

This map shows the geographic impact of Aolin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aolin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aolin Li more than expected).

Fields of papers citing papers by Aolin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aolin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aolin Li. The network helps show where Aolin Li may publish in the future.

Co-authorship network of co-authors of Aolin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Aolin Li. A scholar is included among the top collaborators of Aolin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aolin Li. Aolin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Aolin, et al.. (2025). Intercellular communication after myocardial infarction: Macrophage as the centerpiece. Ageing Research Reviews. 109. 102757–102757. 3 indexed citations
2.
Xu, Chaojie, Aolin Li, Li Lin, et al.. (2024). Conventional ultrasonography enabled with augmented reality needle guidance for percutaneous kidney access: an innovative methodologies randomized controlled trial. International Journal of Surgery. 111(1). 661–676. 1 indexed citations
3.
Li, Aolin, Canqing Yu, Pei Pei, et al.. (2024). Phenotypic Versus Genetic Mismatch of BMI and Type 2 Diabetes: Evidence From Two Prospective Cohort Studies. Diabetes. 74(3). 320–331.
4.
Cao, Congcong, et al.. (2024). Engineering artificial non-coding RNAs for targeted protein degradation. Nature Chemical Biology. 21(3). 393–401. 10 indexed citations
5.
Wang, Yong, et al.. (2024). Mamastrovirus spike protein: Sequence and structural characterization as a basis for understanding cross-species transmission. International Journal of Biological Macromolecules. 282(Pt 6). 137366–137366. 1 indexed citations
6.
Li, Aolin, et al.. (2023). The role of mitochondria in myocardial damage caused by energy metabolism disorders: From mechanisms to therapeutics. Free Radical Biology and Medicine. 208. 236–251. 46 indexed citations
7.
Li, Aolin, et al.. (2023). Factors Affecting the Breastfeeding Duration of Infants and Young Children in China: A Cross-Sectional Study. Nutrients. 15(6). 1353–1353. 5 indexed citations
8.
Zhan, Yonghao, Congcong Cao, Aolin Li, Hongbing Mei, & Yuchen Liu. (2023). Enhanced RNA knockdown efficiency with engineered fusion guide RNAs that function with both CRISPR-CasRx and hammerhead ribozyme. Genome biology. 24(1). 9–9. 9 indexed citations
9.
Cao, Congcong, et al.. (2023). Enhancement of protein translation by CRISPR/dCasRx coupled with SINEB2 repeat of noncoding RNAs. Nucleic Acids Research. 51(6). e33–e33. 18 indexed citations
10.
Wang, Chenguang, Haibo Xu, Wujiao Li, et al.. (2022). Hypertension Promotes the Proliferation and Migration of ccRCC Cells by Downregulation of TIMP3 in Tumor Endothelial Cells through the miR-21–5p/TGFBR2/P38/EGR1 Axis. Molecular Cancer Research. 21(1). 62–75. 8 indexed citations
11.
Gan, Ying, et al.. (2022). Pyroptosis-Related Gene Signature Predicts the Prognosis of ccRCC Using TCGA and Single-Cell RNA Seq Database. Journal of Healthcare Engineering. 2022. 1–12. 4 indexed citations
12.
Zhang, Zhenan, et al.. (2021). Identifying a hypoxia related score to predict the prognosis of bladder cancer: a study with The Cancer Genome Atlas (TCGA) database. Translational Andrology and Urology. 10(0). 4353–4364. 3 indexed citations
13.
Li, Bin, Qian Zhang, Xiaolei Zhang, et al.. (2021). Analysis of the reasons for screening failure in phase I clinical trials in China: a retrospective study of the clinical trials screening process. Annals of Translational Medicine. 9(20). 1564–1564. 4 indexed citations
14.
Lin, Yao, Quan Zhang, Aolin Li, et al.. (2020). Synthetic Artificial Long Non-coding RNA Shows Higher Efficiency in Specific Malignant Phenotype Inhibition Compared to the CRISPR/Cas Systems. Frontiers in Molecular Biosciences. 7. 617600–617600. 9 indexed citations
15.
Su, Zhiguo, Aolin Li, Jiayu Chen, et al.. (2020). Wastewater discharge drives ARGs spread in the coastal area: A case study in Hangzhou Bay, China. Marine Pollution Bulletin. 151. 110856–110856. 52 indexed citations
16.
Li, Aolin, Lin Yao, Yuan Fang, et al.. (2019). Specifically blocking the fatty acid synthesis to inhibit the malignant phenotype of bladder cancer. International Journal of Biological Sciences. 15(8). 1610–1617. 14 indexed citations
17.
Ding, Mengting, Hengji Zhan, Xinhui Liao, et al.. (2018). Enhancer RNA - P2RY2e induced by estrogen promotes malignant behaviors of bladder cancer. International Journal of Biological Sciences. 14(10). 1268–1276. 20 indexed citations
18.
Gao, Qunjun, Yuhan Liu, Haibiao Xie, et al.. (2018). Lentivirus-mediated shRNA targeting <em>MUTYH</em> inhibits malignant phenotypes of bladder cancer SW780 cells. OncoTargets and Therapy. Volume 11. 6101–6109. 7 indexed citations
19.
Zhang, Yan, Aolin Li, Tianjiao Dai, et al.. (2017). Cell-free DNA: A Neglected Source for Antibiotic Resistance Genes Spreading from WWTPs. Environmental Science & Technology. 52(1). 248–257. 226 indexed citations
20.
Lan, Tao, Chen Yang, Shiyu Hu, Aolin Li, & Xinjian Yang. (2017). Is fusion superior to non-fusion for the treatment of thoracolumbar burst fracture? A systematic review and meta-analysis. Journal of Orthopaedic Science. 22(5). 828–833. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026